Cerebrosterol

Cerebrosterol is a lipid of Sterol Lipids (ST) class. Cerebrosterol is associated with abnormalities such as nervous system disorder, Neurodegenerative Disorders, Alzheimer's Disease, Senile Plaques and Hypercholesterolemia. The involved functions are known as Blood - brain barrier function, Oxidation, 5-(carboxyamino)imidazole ribonucleotide mutase activity, cholesterol biosynthetic process and Anabolism. Cerebrosterol often locates in Hepatic, Body tissue, Autosome, brain tissue surgical material and Tissue membrane. The associated genes with Cerebrosterol are CYP27A1 gene, Alleles, INS gene, Apolipoprotein E4 and PLXNB1 gene. The related lipids are Sterols, 7-dehydrocholesterol, 27-hydroxycholesterol, 24-hydroxycholesterol and Dehydrocholesterols. The related experimental models are Mouse Model.

Cross Reference

Introduction

To understand associated biological information of Cerebrosterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Cerebrosterol?

Cerebrosterol is suspected in Hypercholesterolemia, nervous system disorder, Neurodegenerative Disorders, Alzheimer's Disease, Primary open angle glaucoma, Hypertensive disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Cerebrosterol

MeSH term MeSH ID Detail
Hypercholesterolemia D006937 91 associated lipids
Alzheimer Disease D000544 76 associated lipids
Nerve Degeneration D009410 53 associated lipids
Plaque, Amyloid D058225 19 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with Cerebrosterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Cerebrosterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Cerebrosterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Cerebrosterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Cerebrosterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Cerebrosterol?

Mouse Model

Mouse Model are used in the study 'Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation.' (Valenza M et al., 2007).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Cerebrosterol

Download all related citations
Per page 10 20 50 100 | Total 193
Authors Title Published Journal PubMed Link
Ali Z et al. On the regulatory role of side-chain hydroxylated oxysterols in the brain. Lessons from CYP27A1 transgenic and Cyp27a1(-/-) mice. 2013 J. Lipid Res. pmid:23284090
Hughes TM et al. Brain cholesterol metabolism, oxysterols, and dementia. 2013 J. Alzheimers Dis. pmid:23076077
Leoni V and Caccia C Potential diagnostic applications of side chain oxysterols analysis in plasma and cerebrospinal fluid. 2013 Biochem. Pharmacol. pmid:23541982
Freemantle E et al. Analysis of oxysterols and cholesterol in prefrontal cortex of suicides. 2013 Int. J. Neuropsychopharmacol. pmid:23369504
Fourgeux C et al. Single nucleotide polymorphism in the cholesterol-24S-hydroxylase (CYP46A1) gene and its association with CFH and LOC387715 gene polymorphisms in age-related macular degeneration. 2012 Invest. Ophthalmol. Vis. Sci. pmid:22977134
Sodero AO et al. Cholesterol loss during glutamate-mediated excitotoxicity. 2012 EMBO J. pmid:22343944
Popp J et al. Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease. 2012 J. Neurochem. pmid:22845771
Fourgeux C et al. Steady-state levels of retinal 24S-hydroxycholesterol are maintained by glial cells intervention after elevation of intraocular pressure in the rat. 2012 Acta Ophthalmol pmid:22998629
Mateos L et al. side-chain-oxidized oxysterols upregulate ACE2 and Mas receptor in rat primary neurons. 2012 Neurodegener Dis pmid:22236548
Krištofiková Z et al. Interactions of amyloid β peptide 1-40 and cerebrosterol. 2012 Neurochem. Res. pmid:22089933
Hughes TM et al. Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer's disease. 2012 J. Alzheimers Dis. pmid:22377780
Emanuelsson I and Norlin M Protective effects of 27- and 24-hydroxycholesterol against staurosporine-induced cell death in undifferentiated neuroblastoma SH-SY5Y cells. 2012 Neurosci. Lett. pmid:22884615
Saint-Pol J et al. Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-β peptide accumulation. 2012 J. Alzheimers Dis. pmid:22433669
Gamba P et al. Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-β in amplifying neuronal damage in Alzheimer's disease: three partners in crime. 2011 Aging Cell pmid:21272192
Zuliani G et al. Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study. 2011 BMC Neurol pmid:21970714
Jeitner TM et al. Oxysterol derivatives of cholesterol in neurodegenerative disorders. 2011 Curr. Med. Chem. pmid:21428891
Vanmierlo T et al. Cerebral accumulation of dietary derivable plant sterols does not interfere with memory and anxiety related behavior in Abcg5-/- mice. 2011 Plant Foods Hum Nutr pmid:21431910
Mateos L et al. Side chain-oxidized oxysterols regulate the brain renin-angiotensin system through a liver X receptor-dependent mechanism. 2011 J. Biol. Chem. pmid:21628469
Seet RC et al. Oxidative damage in ischemic stroke revealed using multiple biomarkers. 2011 Stroke pmid:21700941
Fourgeux C et al. 24S-hydroxycholesterol and cholesterol-24S-hydroxylase (CYP46A1) in the retina: from cholesterol homeostasis to pathophysiology of glaucoma. 2011 Chem. Phys. Lipids pmid:21531213
Shafaati M et al. Enhanced production of 24S-hydroxycholesterol is not sufficient to drive liver X receptor target genes in vivo. 2011 J. Intern. Med. pmid:21486371
Dujmovic I Cerebrospinal fluid and blood biomarkers of neuroaxonal damage in multiple sclerosis. 2011 Mult Scler Int pmid:22096642
Yamanaka K et al. 24(S)-hydroxycholesterol induces neuronal cell death through necroptosis, a form of programmed necrosis. 2011 J. Biol. Chem. pmid:21613228
Seet RC et al. Biomarkers of oxidative damage in cigarette smokers: which biomarkers might reflect acute versus chronic oxidative stress? 2011 Free Radic. Biol. Med. pmid:21420490
Mast N et al. Cholestenoic Acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain. 2011 Invest. Ophthalmol. Vis. Sci. pmid:20881306
Liao WL et al. Quantification of cholesterol-metabolizing P450s CYP27A1 and CYP46A1 in neural tissues reveals a lack of enzyme-product correlations in human retina but not human brain. 2011 J. Proteome Res. pmid:21049985
Serrano-Pozo A et al. Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers. 2010 Jul-Sep Alzheimer Dis Assoc Disord pmid:20473136
Cartagena CM et al. 24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury. 2010 Brain Res. pmid:20053345
Ullrich C et al. Effects of cholesterol and its 24S-OH and 25-OH oxysterols on choline acetyltransferase-positive neurons in brain slices. 2010 Pharmacology pmid:20571288
Jenner AM et al. The effect of APOE genotype on brain levels of oxysterols in young and old human APOE epsilon2, epsilon3 and epsilon4 knock-in mice. 2010 Neuroscience pmid:20416362
Raina A and Kaul D LXR-α genomics programmes neuronal death observed in Alzheimer's disease. 2010 Apoptosis pmid:20927647
Hudry E et al. Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease. 2010 Mol. Ther. pmid:19654569
Wang Y et al. A second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol). 2010 Biochim. Biophys. Acta pmid:20211758
Shafaati M et al. The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo. 2010 J. Lipid Res. pmid:19474457
Zhao S et al. Polar metabolite of cholesterol induces rat cognitive dysfunctions. 2009 Neuroscience pmid:19699274
Kölsch H et al. CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism. 2009 Eur. Psychiatry pmid:19286353
Leoni V Oxysterols as markers of neurological disease--a review. 2009 Scand. J. Clin. Lab. Invest. pmid:19199127
Liao WL et al. Steroid and protein ligand binding to cytochrome P450 46A1 as assessed by hydrogen-deuterium exchange and mass spectrometry. 2009 Biochemistry pmid:19317426
Prasanthi JR et al. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. 2009 Mol Neurodegener pmid:19126211
Fourgeux C et al. Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels. 2009 Invest. Ophthalmol. Vis. Sci. pmid:19553612
Cook IT et al. 24-hydroxycholesterol sulfation by human cytosolic sulfotransferases: formation of monosulfates and disulfates, molecular modeling, sulfatase sensitivity, and inhibition of liver x receptor activation. 2009 Drug Metab. Dispos. pmid:19589875
Koschack J et al. Serum 24S-hydroxycholesterol and hippocampal size in middle-aged normal individuals. 2009 Neurobiol. Aging pmid:18061309
Solomon A et al. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease. 2009 Neurosci. Lett. pmid:19560513
Honda A et al. Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS. 2009 J. Lipid Res. pmid:18815436
Seet RC et al. Oxidative damage in dengue fever. 2009 Free Radic. Biol. Med. pmid:19427377
Weiner MF et al. Plasma 24S-hydroxycholesterol and other oxysterols in acute closed head injury. 2008 Brain Inj pmid:18568715
Bang HJ et al. A comparison of the potential unfavorable effects of oxycholesterol and oxyphytosterol in mice: different effects, on cerebral 24S-hydroxychoelsterol and serum triacylglycerols levels. 2008 Biosci. Biotechnol. Biochem. pmid:19060413
Rantham Prabhakara JP et al. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on tyrosine hydroxylase and alpha-synuclein in human neuroblastoma SH-SY5Y cells. 2008 J. Neurochem. pmid:19014385
Kristofiková Z et al. Complex of amyloid beta peptides with 24-hydroxycholesterol and its effect on hemicholinium-3 sensitive carriers. 2008 Neurochem. Res. pmid:17717740
Leoni V et al. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease. 2008 Brain pmid:18772220